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Mechanisms of granulocytosis in the absence of CD18
Bruce H. Horwitz, Joseph P. Mizgerd, Martin L. Scott, and Claire M. Doerschuk
Genetic deﬁciency in CD18 leads to dis-
ease characterized by myeloid hyperpla-
sia, including profound granulocytosis
and splenomegaly. Myeloid hyperplasia
could directly result from the disruption
ofCD18functionsessentialtogranulopoi-
esis or basal leukocyte trafﬁcking. Alter-
natively, myeloid hyperplasia could be
reactive in nature, due to disruption of
essential roles of CD18 in leukocyte re-
sponses to microbial challenge. To distin-
guish between these mechanisms, the
hematopoietic systems of lethally irradi-
ated wild-type (WT) mice were reconsti-
tuted with either WT fetal liver cells or
CD18-deﬁcientfetallivercells,oranequal
mixture of both types of cells. Granulocy-
tosisandsplenomegalydevelopedinmice
that received CD18-deﬁcient fetal liver
cells. Splenomegaly was prevented and
granulocytosiswasinhibitedbymorethan
95% in mice that had received both CD18-
deﬁcient and WT fetal liver cells, suggest-
ing that myeloid hyperplasia was largely
reactive in nature. Consistent with this
postulate, the circulating life spans in the
blood and the fraction of neutrophils that
incorporated BrdU in the bone marrow
were not increased for CD18-deﬁcient
neutrophils compared with the WT. How-
ever, these animals did develop mild
granulocytosis compared with mice re-
constituted with WT cells alone, and a
higher percentage of CD18-deﬁcient leu-
kocytes were neutrophils compared with
the WT leukocytes. These observations
suggest that the granulocytosis ob-
served in the absence of CD18 occurs
through at least 2 mechanisms: one that
is dramatically improved by the pres-
ence of WT cells, likely reactive in na-
ture, and a second that is independent
of the WT hematopoietic cells, involving
an alteration in the lineage distribution
of blood leukocytes. (Blood. 2001;97:
1578-1583)
© 2001 by TheAmerican Society of Hematology
Introduction
Leukocyte adhesion deﬁciency (LAD) is characterized by frequent
soft tissue infections and premature mortality.1-3 LAD type I is
caused by a genetic deﬁciency of CD18, the b-chain of the
leukocyte integrins, which are heterodimers of CD11 (CD11a, -b,
-c, or -d) and CD18. This deﬁciency leads to a loss of all
immunologically recognizable CD11 and CD18 and the absence of
all CD11/CD18 function.1,2 Infected tissues from patients with
LAD are generally devoid of extravascular neutrophils, suggesting
that CD11/CD18 complexes are often essential for neutrophils to
emigrate from blood vessels, and that this defect is responsible for
the increased sensitivity to infection. Supporting this hypothesis is
the observation that neutrophils from CD18-deﬁcient patients
exhibit defective adherence to endothelium.1,2 Mice lacking CD18
as the result of gene targeting demonstrate similar symptoms to
patients with LAD, including defective neutrophil emigration and
frequent soft tissue infections.4-6
In addition to frequent infections, patients and animals lacking
CD18 develop marked peripheral blood granulocytosis and my-
eloid hyperplasia in the spleen and marrow.5 However, the mecha-
nisms that lead to the development of granulocytosis have not been
clearly delineated. In this report, we have attempted to distinguish
between a mechanism in which granulocytosis persists in the
presence of wild-type (WT) hematopoietic cells, which we will
refer to as an intrinsic mechanism, and a mechanism in which
granulocytosis is resolved by the presence of WT hematopoietic
cells, which we will refer to as a reactive mechanism. Intrinsic
mechanisms of granulocytosis may include alterations in the
production, emigration, or circulating life span of neutrophils, or
their precursors. For instance, the absence of CD18 on hematopoi-
etic precursors may lead to the excessive production of neutrophils.
Another integrin, b1, has been reported to inﬂuence the frequency
of hematopoietic precursors.7 Other possibilities include defective
emigration of CD18-deﬁcient neutrophils from the circula-
tion,4,6,8-12 resulting in peripheral blood granulocytosis, whereas
longer transit times within the sites of hematopoiesis, such as the
bone marrow,13 could lead to the accumulation of neutrophils in the
bone marrow and spleen. Neutrophils lacking CD11b, one of the
binding partners of CD18, exhibit reduced rates of spontaneous
apoptosis,14 raising the possibility that decreased apoptosis of
CD18-deﬁcient neutrophils could play an etiologic role in the
development of granulocytosis. If any of these mechanisms
predominate, then granulocytosis should persist in the presence of
WT hematopoietic cells. In contrast to an intrinsic mechanism, a
reactive mechanism for the development of granulocytosis may
involve excessive microbial overgrowth in the face of defective
neutrophil function,1,2,5,15 leading to the chronic stimulation of the
bone marrow and the production of large numbers of granulocytes.
This reaction would be suppressed by the presence of sufﬁcient
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normal antimicrobial function.
To distinguish between an intrinsic and a reactive mechanism of
granulocytosis, we endeavored to compare the properties of WT
and CD18-deﬁcient neutrophils in the presence of WT hematopoi-
etic cells. To accomplish this, mice with mixtures of WT and
CD18-deﬁcient neutrophils in their blood were generated both
stably, by reconstitution of the hematopoietic system of lethally
irradiated WT mice with mixtures of WT and CD18-deﬁcient fetal
liver cells, and transiently, by adoptive transfer of a mixture of WT
and CD18-deﬁcient blood cells into nonirradiated WT hosts. Our
results suggest that granulocytosis occurs through both reactive and
intrinsic mechanisms.
Materials and methods
Hematopoietic reconstitutions
The hematopoietic systems of C57BL/6-CD45.1 host mice were reconsti-
tuted with fetal liver cells as described.6,16 Brieﬂy, CD18-deﬁcient mice or
WT mice of similar randomly mixed C57BL/6 X129/Sv backgrounds,
which express the CD45.2 allele of leukocyte common antigen, were mated
with the like genotype. Fetal livers were harvested on day 14 of gestation
and single-cell suspensions prepared. 2 3 106 fetal liver cells of either
genotype or a mixture containing 1 3 106 fetal liver cells of each genotype
were injected intravenously into host C57BL/6-CD45.1 mice that had
received radiation doses of 800 and 400 rads from a cesium-137 source
separated by 3 hours. After transplantation, mice received trimethoprim-
sulfamethoxazole in their drinking water for 1 month. Mice were main-
tained in full-barrier facilities.
Flow cytometry
For ﬂow cytometric analysis of blood leukocytes, the following antibodies
were used: ﬂuorescein isothiocyanate (FITC)–conjugated CD11a (M17/4,
Pharmingen, San Diego, CA), phycoerythrin (PE)–conjugated Gr-1 (RB6-
8C5, Pharmingen), PE-conjugated B220 (Pharmingen), and biotinylated
CD45.2 (104, Pharmingen). Biotin was revealed with either streptavidin-
Red670 (Gibco/BRL, Gaithersburg, MD) or streptavidin-allophycocyanin
(Pharmingen). Gr-1bright cells had forward- and side-scatter characteristics
consistent with neutrophils. Gr-1 was used to identify neutrophils, and
CD45.2 was used to identify donor cells. In all experiments, reconstitution
with CD45.21 donor cells was essentially 100%. The total absolute
neutrophil count (ANC) was determined by multiplying the fraction of
CD45.21 leukocytes that were Gr-1bright by the white blood cell (WBC)
count. In mixed chimeras, the ANC for each genotype was determined by
multiplying the fraction of Gr-1bright cells that were CD11a1 or CD11a2 by
theANC. The WBC count was determined with a hemocytometer.
Analysis of colony-forming units in culture
The 1.5 3 104 bone marrow cells from hosts animals that had received 1:1
mixtures of WT and CD18-deﬁcient fetal liver cells 6 months previously
were plated in Methocult GF M3543 (Stemcell Technologies, Vancouver,
BC, Canada). Seven to 10 days later, well-separated colonies were
harvested and incubated overnight at 55°C in 0.2 M NaCl, 5 mM EDTA,
100 mm Tris-HCl pH 8.0, 0.4% sodium dodecyl sulfate, and 100 mg/mL
proteinase K. The following day, DNA was extracted with phenol:
chloroform. The 2 mL of DNA was used in a 25 mL 3 primer polymerase
chain reaction (PCR) (94°C for 1 minute, 66°C for 2.5 minutes 3 40 cycles)
with the following primers: CD18-59WT-59-CTT CCT GGG ATC TGG
TGA GTT CTG-39; CD18-39-WT-59-ATT CCT GGG ACA CAG CTG
GGG AGA C-39; CD18-39NEO-59-GAG AAC CTG CGT GCAATC CAT
CTT G-39. WT (smaller) and CD18-deﬁcient (larger) PCR products could
be distinguished by size with standard 2% agarose/Tris/borate/EDTA
electrophoresis. Of 84 colonies analyzed, 74 gave unambiguous results.
Adoptive transfer
For adoptive transfer experiments, blood was collected from the inferior
vena cava of donor mice into a heparinized syringe. Blood from WT and
CD18-deﬁcient animals was mixed and 250 mL immediately injected into
unirradiated C57BL/6-CD45.1 hosts. Hosts were bled by retro-orbital
puncture at the indicated times after injection. The percentage of donor
neutrophils and the ratio of WT to CD18 neutrophils within the donor
population were determined by ﬂow cytometry.
BrdU labeling of bone marrow neutrophils
For determining BrdU-labeling index of bone marrow neutrophils, host
animals were injected with 0.6 mg of BrdU intraperitoneally twice,
separated by 12 hours.17 Twenty-four hours after the ﬁrst injection, bone
marrow cells were harvested and red blood cells were lysed. Cells were
stained with PE-conjugated Gr-1 and biotinylated CD11a, and biotin was
revealed with streptavidin-Red670. After washing, the cells were resus-
pended in 0.5 mLof cold 0.15 M NaCl and 1.2 mLof ice-cold 100% ethanol
was added dropwise, followed by a 30-minute incubation on ice. Cells were
washed with cold phosphate-buffered saline (PBS) and resuspended in 1%
paraformaldehyde in PBS with 0.05% Tween-20 and incubated for 30
minutes at room temperature and then overnight at 4°C. The following day,
cells were resuspended in 1 mLof a solution consisting of 0.15 M NaCl, 4.2
mM MgCl2,1 0mM HCl, and 100 m/mL DNase (Sigma, St Louis, MO,
DN-25), and incubated for 30 minutes at 25°C. Cells were washed with cold
PBS and resuspended in 50 mL of FITC-conjugated anti-BrdU (Becton
Dickinson, San Jose, CA), diluted 1:5 in PBS, and incubated at 25°C for 30
minutes. Cells were washed in PBS and then analyzed by ﬂow cytometry.
Statistics
Data sets were compared by analysis of variance using Statistica software
(Statsoft, Tulsa, OK). Because data collected from the 6-month animals
failed Levene’s test for homogeneity of variance, and the means and
standard deviations were positively correlated, all data from 6-month
animals were log transformed before statistical analyses. Individual groups
were compared post hoc by using either the Tukey honest signiﬁcant
different test or Spjotvoll and Stoline’s Tukey honest signiﬁcant difference
test for unequal sample sizes. Differences between groups were considered
statistically signiﬁcant when P , .05.
Results and discussion
Granulocytosis develops after hematopoietic reconstitution
with CD18-deﬁcient fetal liver cells
Expression of the b2-integrins is limited to hematopoietic tissue,
and therefore phenotypic defects observed in animals genetically
deﬁcient in CD18 are also assumed to be limited to the hematopoi-
etic system. To test this assumption, WT mice were lethally
irradiated and injected with either WT or CD18-deﬁcient fetal liver
cells. Donor cells carried the CD45.2 allele of leukocyte common
antigen, whereas host mice did not, such that donor cells could be
deﬁnitively identiﬁed by expression of the CD45.2 allele. One or 6
months after transplantation, ﬂow cytometry demonstrated that
host animals were reconstituted with donor-derived hematopoietic
cells and that WT donor neutrophils expressed CD11a, whereas
CD18-deﬁcient neutrophils did not. Animals reconstituted with
CD18-deﬁcient donor fetal liver cells had signiﬁcantly higher
circulating ANCs 1 month after transplantation (Figure 1A-B).
After 6 months, both total WBC counts and ANCs were increased
in the animals that received CD18-deﬁcient cells (Figure 1A-B).
Furthermore, animals reconstituted with CD18-deﬁcient fetal liver
cells demonstrated signiﬁcant splenomegaly at 6 months (Figure
1C), and histologic analysis suggested that this was secondary to
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ﬁndings are characteristic of CD18-deﬁcient mice and demonstrate
that the absence of CD18 in hematopoietic cells alone is sufﬁcient
to cause granulocytosis.
The presence of wild-type hematopoietic cells limits
granulocytosis
Todeterminewhethergranulocytosiswoulddevelopinanimalsreconsti-
tuted with mixtures of WT and CD18-deﬁcient hematopoietic cells,
lethally irradiated hosts were injected with 50:50 mixtures of WT and
CD18-deﬁcient fetal liver cells. Six months after transplantation, the
presence of both WT and CD18-deﬁcient neutrophils in the blood of
host animals was veriﬁed by ﬂow cytometry (Figure 2).Although donor
fetallivercellsweremixedata1:1ratio,wefoundthatthepercentageof
neutrophils that were CD18-deﬁcient varied widely but in these
experiments was greater than 50% for all animals analyzed (Figure 2).
These data demonstrate that experimental animals were reconstituted by
bothWTandCD18-deﬁcientfetallivercells.Onemonthaftertransplan-
tation, there was a small but not statistically signiﬁcant increase in the
ANCs of these animals compared with control animals. By 6 months
after adoptive transfer, ANCs were signiﬁcantly increased compared
with the animals transplanted with WT cells, but markedly lower than
the ANCs in animals transplanted with CD18-deﬁcient fetal liver cells
alone (Figure 1B). Although the mean ANC increased 65-fold in mice
reconstituted with CD18-deﬁcient cells alone, the meanANC increased
only 2-fold in mice reconstituted with mixtures of WT and CD18-
defcient cells. Six months after the transfer of mixtures of both WT and
mutant cells, neither splenic weights nor total circulating WBC counts
differed from the animals reconstituted with WT cells alone, whereas as
demonstrated previously, both parameters were signiﬁcantly increased
in animals reconstituted with CD18-deﬁcient cells alone (Figure 1A,C).
There were only minimal signs of myeloid hyperplasia within the
splenic red pulp of mice reconstituted with mixtures of WT and
CD18-deﬁcient cells (data not shown). These results demonstrate that
the presence of WT hematopoietic cells largely, although not com-
pletely, suppresses the development of granulocytosis by cells lacking
CD18. This suggests that granulocytosis in the absence of CD18 is
caused predominantly by a reactive mechanism.
An important caveat to the interpretation of this mixing
experiment is the possibility that CD18-deﬁcient hematopoietic
precursors compete poorly with WT hematopoietic precursors.
This could lead to a situation in which granulocytosis in the
presence of WT cells is suppressed because there are fewer
CD18-deﬁcient precursors, despite the ability of these precursors to
produce higher numbers of neutrophils than WT precursors. To
address this possibility, we compared the percentage of colony-
forming units in culture (CFU-C) in the bone marrow that were
CD18-deﬁcient to the percentage of neutrophils in the blood that
Figure 2. Host animals were reconstituted with both WT and CD18-deﬁcient
neutrophils. The percentage of neutrophils that were CD18-deﬁcient was deter-
mined by ﬂow cytometry 6 months after injection of host animals with 50:50 mixtures
of WT and CD18-deﬁcient fetal liver cells.
Figure 1. Myeloid hyperplasia is inhibited by the presence of WT hematopoietic
cells. (A) WBC counts of reconstituted animals 1 and 6 months after transplantation.
WT refers to animals that received only WT fetal liver cells, CD18 to animals that
received only CD18-deﬁcient fetal liver cells, and Mix to animals that received 50:50
mixtures of WT and CD18-deﬁcient fetal liver cells. (B) Absolute neutrophil counts of
reconstituted animals 1 and 6 months after transplantation. (C) Splenic weights of
reconstituted animals 6 months after transplantation. *, increase in Mix is signiﬁcant
(P , .05) compared with WT at same time point. **, increase in CD18 is signiﬁcant
(P , .05) compared with WT or Mix at same time point.
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mixtures of WT and CD18-deﬁcient fetal liver cells. To determine
CFU-C genotypes, bone marrow cells were plated in methylcellu-
lose with appropriate growth factors, and 7 to 10 days later
individual CFUs were harvested and DNAprepared. The genotype
of each CFU was determined by PCR. In the 2 animals examined,
the percentage of CD18-deﬁcient CFU-C was 80% and 92%,
whereas the percentage of CD18 neutrophils in the blood was 85%
and 77%, respectively. This limited experiment suggests that the
lack of extensive granulocytosis in animals that received mixtures
of WT and CD18-deﬁcient fetal liver cells is not caused by the
inability of CD18-deﬁcient granulocyte precursors to compete with
WT precursors in the bone marrow.
CD18-deﬁciency does not increase the time spent in blood or
bone marrow
Although the vast majority of the peripheral blood granulocytosis
was prevented by the presence of WT cells, the ANCs remained
signiﬁcantly elevated in mice that had received a mixture of WT
and CD18-deﬁcient fetal liver cells 6 months previously. Because
CD11/CD18 facilitates neutrophil adhesion to endothelial cells
lining the blood vessels, and because CD11/CD18 can expedite
neutrophil apoptosis,14 it has been proposed that the loss of CD18
could directly contribute to peripheral blood granulocytosis by
increasing the circulating life span of neutrophils. Indeed, examina-
tion of a CD18-deﬁcient human indicated that this patient’s
neutrophils circulated longer than historic control values,18 al-
though the disease state of this patient complicated the interpreta-
tion. To compare the circulating kinetics of WT and CD18
neutrophils in the same physiologic environment, we performed an
adoptive transfer experiment. Blood was collected from WT and
CD18-deﬁcient mice, mixed, and immediately injected intrave-
nously into 4 C57BL/6-CD45.1 hosts. Blood was sampled from
host mice at various times after injection, and the percentage of
donor (CD45.21) neutrophils and the distribution of WT to
CD18-deﬁcient neutrophils within the donor population was deter-
mined simultaneously by ﬂow cytometry.As expected, the number
of donor neutrophils in the circulation decreased over time (Figure
3A). However, the proportions of WT and CD18-deﬁcient donor
neutrophils remained virtually constant throughout the 2 hours
sampling period (Figure 3B), and were comparable to the original
mixture before injection.
To determine whether longer periods would reveal differences
in circulating kinetics between WT and CD18-deﬁcient neutro-
phils, a second set of 4 C57BL/6-CD45.1 host mice received
intravenous injections of blood mixed from WT and CD18-
deﬁcient donor mice. Again, the percentage of donor neutrophils
that were CD18-deﬁcient was comparable to the original injection
after 10 minutes, and it did not signiﬁcantly differ after 3 hours
(Figure 3C). However, by 6 hours, the percentage of circulating
donor neutrophils that were CD18-deﬁcient signiﬁcantly decreased
compared with either 10 minutes or 3 hours after injection (Figure
3C). These data suggest that, between 3 and 6 hours after injection,
the CD18-deﬁcient neutrophils disappeared from the circulation at
a greater rate than the WT neutrophils. The mechanisms respon-
sible for this accelerated loss of CD18-deﬁcient neutrophils
compared with the WT, and the physiologic signiﬁcance of this
alteration, remain uncertain. However, because this alteration
would tend to decrease rather than increase the number of
CD18-deﬁcient neutrophils in the blood, these data suggest that the
peripheral blood granulocytosis of CD18-deﬁcient mice does not
result from prolonged circulating life spans of CD18-deﬁcient
neutrophils.
To determine the transit time neutrophils spend in the bone
marrow, newly formed neutrophils were labeled with the thymidine
analog BrdU. BrdU labeling has been used previously to evaluate
the transit time of postmitotic hematopoietic cells through the bone
marrow. The Gr-11 compartment within the bone marrow has been
reported to be predominantly postmitotic19 and our preliminary
Figure 3. The circulating life spans of CD18-deﬁcient neutrophils is not
increased compared with WT. C57BL/6-CD45.1 host animals were injected
intravenously with mixtures of blood collected from WT and CD18-deﬁcient animals.
(A) The numbers of blood neutrophils (Gr-1bright), which were of donor origin
(CD45.21), were determined by counting and ﬂow cytometry at the indicated time
points after injection. (B, C)The percentage of donor neutrophils (CD45.21, Gr-1bright)
that were CD18-deﬁcient (CD11a2) was determined by ﬂow cytometry at the
indicated time points. The data point at time 0 refers to the percentage of
CD18-deﬁcient neutrophils in the original mixture before injection into the host
animal. * indicates signiﬁcant (P , .05) decrease in the percentage of CD18-deﬁcient
neutrophils compared with the earlier time points. Each point represents the mean 6
SEM for 4 host mice.
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index was calculated as the percentage of Gr-1bright cells recovered
from the bone marrow that were labeled with BrdU. If CD18-
deﬁcient neutrophils spend greater time in the bone marrow, they
should have a decreased BrdU-labeling index. To compare the
BrdU-labeling index, host animals reconstituted with equal mix-
tures of WT and CD18-deﬁcient fetal liver cells 6 months
previously were injected with BrdU twice, at times 0 and 12 hours.
Twenty-four hours after the ﬁrst injection, the animals were killed,
and the bone marrow cells were stained simultaneously for CD11a,
Gr-1, and BrdU.As shown inTable 1, the labeling index ofWTand
CD18-deﬁcient bone marrow neutrophils was virtually identical
(36% 6 1.1% vs 37% 6 2.6%). The observation that approxi-
mately 30% of the Gr-11 positive cells were labeled within a
24-hour period is consistent with previous estimates that used
BrdU-labeling techniques in which the transit time of neutrophils
through the postmitotic pool in the bone marrow was about 60
hours.20This suggests that the bone marrow transit times of theWT
and CD18-deﬁcient neutrophils are similar.
Altogether, these data demonstrate that, within the same physi-
ologic environment, neither the circulating life span nor the bone
marrow transit time of CD18-deﬁcient neutrophils are increased
compared with the WT. These results are consistent with the
hypothesis that granulocytosis in the absence of CD18 is not caused
by intrinsic defects in neutrophil trafﬁcking.
Alteration in leukocyte distribution in the absence of CD18
The data presented above strongly argue that granulocytosis in the
absence of CD18 is predominantly a reactive process because it can
be repressed by the presence of WT hematopoietic cells. Nonethe-
less, there have been reports that other integrin molecules can
inﬂuence the development of hematopoietic precursors,7 and it has
been well-documented that b2-integrins are expressed in certain
hematopoietic precursor populations.21,22 To evaluate the lineage
distribution of WT and CD18-deﬁcient leukocytes, we compared
the percentage of WT or CD18-deﬁcient leukocytes that were
neutrophils in the blood of animals that had received either WT
fetal liver cells or CD18-deﬁcient fetal liver cells, or mixtures of
both WT and CD18-deﬁcient fetal liver cells. To accomplish this,
blood leukocytes were stained with CD11a, Gr-1, and CD45.2 and
analyzed by ﬂow cytometry. Donor leukocytes were identiﬁed by
forward- and side-scatter characteristics and staining with CD45.2.
Within this gate, the percentage of CD11a1 cells that were Gr-1bright
was determined as a measure of the percentage of WT leukocytes
that were neutrophils, and the percentage of CD11a2 cells that were
Gr-1bright indicated the percentage of CD18-deﬁcient leukocytes
that were neutrophils (Figure 4A). As expected, we observed an increase in the percentage of leukocytes that were neutrophils in
animals that had received CD18-deﬁcient fetal liver cells alone
(Figure 4B). More surprisingly, in animals that had received
mixtures of WT and CD18-deﬁcient fetal liver cells, there was also
an increase in the percentage of CD18-deﬁcient leukocytes that
were neutrophils compared with the percentage of WT leukocytes
that were neutrophils (Figure 4B). This was accompanied by a
reciprocal decrease in the percentage of CD18-deﬁcient leukocytes
thatwerepresumablymononuclearcells(ie,notGr-1bright).Indepen-
dent staining for B cells with B220 reﬂected this change, as the
percentage of CD18-deﬁcient leukocytes that were B cells was
decreased compared with the percentage of WT leukocytes that
were B cells (data not shown).
In animals that received mixtures of WT and CD18-deﬁcient
fetal liver cells, the increase inANCs and the selective expansion of
CD18-deﬁcient neutrophils relative to other blood cells suggest
Figure 4. WT WBCs only partially prevent the increase in CD18-deﬁcient
leukocytes that are neutrophils. (A) To determine the percentage of WT or
CD18-deﬁcient leukocytes that were Gr-11, blood leukocytes were stained and
analyzed by ﬂow cytometry as described in the text. The dot plot is an example of
blood leukocytes derived from a CD45.11 host that had received a 1:1 mixture of WT
and CD18-deﬁcient fetal liver cells 6 months previously. The plot shows the CD11a
and Gr-1 staining proﬁles of CD45.21 cells that fall within the forward- and
side-scatter leukocyte gate. The percentage of cells that fall within each quadrant is
shown. (B) The percentage of WT or CD18-deﬁcient leukocytes that were neutrophils
was determined by ﬂow cytometry. WT and CD18 refer to WT or CD18-deﬁcient
leukocytes from host animals that had received either WT or CD182/2 fetal liver cells
alone. Mix-WT and Mix-CD18 refers to WT and CD182/2 leukocyte populations,
respectively, from animals that had received mixtures of both WT and CD18-deﬁcient
fetal liver cells. *, increase in the percentage of Mix-CD18 is signiﬁcant (P , .05)
compared with WT or Mix-WT. **, increase in CD18 is signiﬁcant (P , .05) compared
with WT, Mix-WT, and Mix-CD18.
Table 1. Percentage of wild-type and CD182/2 bone marrow neutrophils that
incorporated BrdU
Neutrophil
genotype
Animal
Average 123
Wild type 37 35 36 36 6 1.1
CD182/2 35 39 38 37 6 2.6
Animals reconstituted with mixtures of wild-type and CD182/2 hematopoietic
cells 6 months previously were labeled with BrdU for 24 hours. Expression of Gr-1
and incorporation of BrdU were determined by ﬂow cytometry. The percentages of
wild-type and CD182/2 neutrophils (Gr-11) that incorporated BrdU are shown. The
percentages of Gr-11 cells that were CD18-deﬁcient were 85%, 83%, and 79% in
animals 1, 2, and 3, respectively.Aseparate experiment, again with 3 mice, conﬁrmed
no differences in BrdU-labeling indices between WT and CD18-deﬁcient neutrophils
in the marrow.
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of circulating leukocytes. This alteration in leukocyte distribution
was a consistent ﬁnding in all mice that received mixtures of
CD18-deﬁcient and WT fetal liver cells, regardless of the ratio of
CD18-deﬁcient to WT leukocytes in the particular animal. Further-
more, this alteration was observed in animals that received lower
ratios of CD18-deﬁcient to WT fetal liver cells in the initial
transplantation step (data not shown). Given our inability to
identify defects in the trafﬁcking of postmitotic neutrophils, we
suggest that this alteration is caused by an intrinsic alteration of
hematopoiesis in the absence of CD18. Further studies will be
necessary to conclusively determine the roles of CD18 in establish-
ing the lineage distribution of circulating leukocytes. The lineage
distribution was further skewed in the mice reconstituted with
CD18-deﬁcient cells alone than in the CD18-deﬁcient population
of leukocytes in mice reconstituted with mixtures of WT and
CD18-deﬁcient cells, suggesting that a reactive component may
exacerbate the skewing of lineage distributions intrinsic to CD18-
deﬁcient leukocytes.
Humans and mice with CD18-deﬁciency develop granulocyto-
sis. There appears to be several mechanisms underlying this
abnormality. More than 95% of the granulocytosis is suppressed
when WT neutrophils are present. We suggest that the most likely
explanationforthisphenomenonisthatCD18-deﬁcientneutrophils
exhibit defective antimicrobial functions, resulting in infection,
subsequent stimulation of the bone marrow, and reactive
granulocytosis. When WT neutrophils are present, they provide
antimicrobial functions that limit granulocytosis, despite the
presence of neutrophils lacking CD18. However, even in the
presence of WT neutrophils, a mild but signiﬁcant granulocyto-
sis develops over time, and the percentage of leukocytes that are
neutrophils is consistently higher for the CD18-deﬁcient popula-
tion of leukocytes than for the WT population. These data
suggest that intrinsic mechanisms may be contributing to the
granulocytosis as well. Alterations in circulating life span
appear unlikely, based on the observation that CD18-deﬁcient
neutrophils are cleared from the circulation no slower than WT
neutrophils. The observation that the BrdU labeling is similar
suggests that turnover rate in the bone marrow is unchanged,
although this does not exclude an intrinsic alteration in hemato-
poietic lineage commitment or an alteration in release from the
bone marrow after a stressful stimulus. The data suggesting that
the percentages of WT and CD18-deﬁcient CFU-C in the
marrow parallels the percentage of WT and CD18-deﬁcient
neutrophils in the blood argues that if there is an alteration in
hematopoietic lineage commitment, it is occurring before develop-
ment of CFU-C. It is possible that a defect in the ability of an early
CD18-deﬁcient hematopoietic precursor or stem cell to compete
with WT cells could lead both to the suppression of granulocytosis
and the alteration of lineage commitment that we have observed. In
this scenario, a small number of CD18-deﬁcient hematopoietic
precursors could be producing an increased number of granulo-
cytes per precursor. This could lead to equivalent numbers of WT
and CD18-deﬁcient neutrophils in the blood but a paucity of
CD18-deﬁcient mononuclear cells, leading to a skewing of the
lineage distribution. Evaluating this possibility will require detailed
analyses of early hematopoietic progenitors beyond the scope of
this study. Thus, the exact mechanisms underlying the intrinsic
component of the granulocytosis remain to be determined. The
dysregulation of circulating neutrophils resulting from CD18
deﬁciency is clearly complex and multifactorial, likely resulting
from the loss of CD18 functions essential to leukocyte lineage
distribution combined with the loss of CD18 functions essential to
host defense and homeostasis.
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